| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

abrdn World Healthcare Fund Q1 2025 Commentary

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

abrdn Ultra Short Municipal Income Fund Q1 2025 Commentary

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

abrdn U.S. Small Cap Equity Fund Q1 2025 Commentary

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

abrdn Total Dynamic Dividend Fund Q1 2025 Commentary

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |

abrdn Life Sciences Investors Q1 2025 Commentary